Next Article in Journal
Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle
Next Article in Special Issue
The Molecular Interplay between Human Oncoviruses and Telomerase in Cancer Development
Previous Article in Journal
Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis
Previous Article in Special Issue
Oncogenic and Stemness Signatures of the High-Risk HCMV Strains in Breast Cancer Progression
 
 
Article

Article Versions Notes

Cancers 2022, 14(19), 4895; https://doi.org/10.3390/cancers14194895
Action Date Notes Link
article pdf uploaded. 6 October 2022 13:52 CEST Version of Record https://www.mdpi.com/2072-6694/14/19/4895/pdf-vor
article supplementary file uploaded. 6 October 2022 13:52 CEST - https://www.mdpi.com/2072-6694/14/19/4895#supplementary
article xml file uploaded 10 October 2022 11:16 CEST Original file -
article xml uploaded. 10 October 2022 11:16 CEST Update https://www.mdpi.com/2072-6694/14/19/4895/xml
article pdf uploaded. 10 October 2022 11:16 CEST Updated version of record https://www.mdpi.com/2072-6694/14/19/4895/pdf
article html file updated 10 October 2022 11:17 CEST Original file -
article supplementary file uploaded. 13 October 2022 03:31 CEST - https://www.mdpi.com/2072-6694/14/19/4895#supplementary
article html file updated 13 October 2022 03:32 CEST Update -
article supplementary file uploaded. 13 October 2022 03:32 CEST - https://www.mdpi.com/2072-6694/14/19/4895#supplementary
article html file updated 13 October 2022 03:33 CEST Update -
article html file updated 28 February 2023 16:53 CET Update -
article html file updated 1 March 2023 15:22 CET Update https://www.mdpi.com/2072-6694/14/19/4895/html
Back to TopTop